))
Episode 44: Max Darnell- CEO & Co-Founder at Modulus Therapeutics
Manage episode 382347664 series 3526490
Treść dostarczona przez Vial. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Vial lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
Max Darnell, CEO and co-founder of Modulus Therapeutics, takes us through his thrilling journey from bioengineering and systems biology to launching a biotech startup. Max unveils how his team's curiosity and motivation, along with their high throughput discovery platform, are revolutionizing cell and cell therapy component designs. Hear how Modulus is making strides in the autoimmune space and harnessing the power of DNA barcoding and sequencing to transform traditional assays into high throughput screens.
First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.
Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.
🎧 Stay in the Loop!
For the latest news and updates, visit our website: https://vial.com
Follow us on social media for real-time insights:
Twitter: https://twitter.com/VialTrials
LinkedIn: https://www.linkedin.com/company/vialtrials
Rozdziały
1. Episode 44: Max Darnell- CEO & Co-Founder at Modulus Therapeutics (00:00:00)
2. Revolutionizing Cell Therapy Design (00:00:06)
3. Advancements in Cell Therapy Design (00:09:27)
62 odcinków
Udostępnij
